Sen. Menendez, Rep. Pascrell Sound New Alarms in COVID Drug Politicization
July 03, 2020
July 03, 2020
WASHINGTON, July 3 -- Sen. Robert Menendez, D-New Jersey, issued the following news release on July 2:
Continuing their crusade against politicization of the COVID-19 drug approval process by the Trump Administration, U.S. Sen. Bob Menendez (D-NJ) and Congressman Bill Pascrell, Jr. (N.J.-09) have written a new letter to U.S. Food and Drug Administration (FDA) Commissioner Stephen Hahn again urging the FDA to be guided by science and not political considerations in helping find a vac . . .
Continuing their crusade against politicization of the COVID-19 drug approval process by the Trump Administration, U.S. Sen. Bob Menendez (D-NJ) and Congressman Bill Pascrell, Jr. (N.J.-09) have written a new letter to U.S. Food and Drug Administration (FDA) Commissioner Stephen Hahn again urging the FDA to be guided by science and not political considerations in helping find a vac . . .